To date several research groups have demonstrated the ability of thiazolidinedione (TZD, class of PPARγ ligands) to attenuate the growth of pancreatic cancer cells in vitro, which was associated to G1 cell cycle arrest and cell differentiation and to increased apoptotic cell death [43]. This evidence concerns the gene PPARG and familial pancreatic carcinoma.